A carregar...
Live-attenuated H1N1 influenza vaccine candidate displays potent efficacy in mice and ferrets
Currently, influenza vaccine manufacturers need to produce 1–5 x 10(7) PFU of each vaccine strain to fill one dose of the current live-attenuated-influenza-vaccine (LAIV). To make a single dose of inactivated vaccine (15 ug of each hemagglutinin), the equivalent of 10(10) PFU of each vaccine strains...
Na minha lista:
| Publicado no: | PLoS One |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Public Library of Science
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6791556/ https://ncbi.nlm.nih.gov/pubmed/31609986 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0223784 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|